2011 PLENARY AND PARALLEL SESSIONS
Sunday, November 6
8:00 – 9:30am Transplant Plenary I
10:30am – Noon Transplant Plenary II
1:15 – 2:45pm
Parallel 1: DILI/Acute Liver Failure
Parallel 2: Non-alcoholic Steatohepatitis: Translational Studies
3:00 – 4:30pm
Parallel 3: HBV: Pathogenesis
Parallel 4: HCV: Refining the Use of Direct-Acting Antivirals
Parallel 5: Hepatitis C: From Immunology to Viral Clearance
Parallel 6: Hepatotoxicity: Signaling and Survival
Parallel 7: Liver Donation and Allocation
Parallel 8: Non-alcoholic Steatohepatitis: Basic Approaches
Parallel 9: Pathogenesis and Treatment of Alcoholic Liver Disease
Parallel 10: Signal Transduction, Nuclear Receptors
Parallel 11: Transport and Bile Acid Metabolism
4:45 – 6:15pm
Parallel 12: HCV Therapy: Preclinical and Early Clinical Development
Parallel 13: HCV: New Insights in Pathogenesis and Diagnosis
Parallel 14: Hepatitis C: From Genomics to Virology
Parallel 15: Improving Effectiveness and Quality of Care in Liver Patients
Parallel 16: Pediatric Hepatology: Pathogenesis and New Therapies
Parallel 17: Transplantation for HCC and Other Non-viral Diseases
Monday, November 7
8:00 – 9:30am Presidential Plenary I
11:00am – 12:30pm Presidential Plenary II
1:15 – 2:45pm
Parallel 18: Basic Mechanisms of Fibrosis
Parallel 19: Biliary Epithelium: Secretion and Development
2:45 – 4:15pm
Late-breaking Abstracts
3:00 – 4:30pm
Parallel 20: Autoimmune and Cholestatic Liver Disease
Parallel 21: Experimental Portal Hypertension
Parallel 22: Experimental Targets for Fibrosis
Parallel 23: Host Factors in HCV Progression and Treatment
Parallel 24: Monitoring HCV Therapy and Outcomes
Parallel 25: Natural History of Hepatitis B
Parallel 26: Stem Cells in Liver Diseases and Cancer
Parallel 27: Viral Hepatitis and Transplantation
4:45 – 6:15pm
Parallel 28: Cell Biology of the Liver
Parallel 29: Epidemiology and Diagnosis of Hepatobiliary Neoplasia
Parallel 30: Management of Portal Hypertension
Parallel 31: Mechanisms of Hepatic Carcinogenesis
Parallel 32: Non-alcoholic Steatohepatitis: Clinical Studies
Parallel 33: Pediatric Hepatology: Biomarkers and Disease Modeling
Tuesday, November 8
8:00 – 9:30am Presidential Plenary III: Viral Hepatitis
10:45am– 12:15pm
Parallel 34: Complications of Cirrhosis
Parallel 35: HBV: Treatment
Parallel 36: HCV: Epidemiology and Natural History
Parallel 37: HCV: Therapeutic Horizons
Parallel 38: Hepatitis B: Virology and Immunology
Parallel 39: Immunity in the Liver: New Horizons
Parallel 40: Treatment of Hepatobiliary Neoplasia
POSTER SESSIONS
This exciting component of The Liver Meeting® extends learning beyond the oral sessions, giving you the opportunity to discuss the details of important research in the hepatology field individually with the authors. More than 1,000 basic science and clinical posters will be presented.
Saturday, November 5 2:00 – 7:30 pm
Sunday, November 6 8:00 am – 5:30 pm
Monday, November 7 8:00 am – 5:30 pm
Tuesday, November 8 8:00 am – Noon
LATE-BREAKING ABSTRACTS
Late-breaking abstract sessions will take place on Monday, November 7.